11/25
09:08 am
imrx
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/25
08:00 am
imrx
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference
11/15
01:42 am
imrx
Immuneering (NASDAQ:IMRX) was upgraded by analysts at
Wall Street Zen
High
Report
11/13
09:01 am
imrx
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Medium
Report
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
11/12
09:14 pm
imrx
Immuneering Corporation (IMRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Immuneering Corporation (IMRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
04:05 pm
imrx
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
Low
Report
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
11/11
05:42 pm
imrx
Immuneering Q3 2025 Earnings Preview [Seeking Alpha]
Low
Report
Immuneering Q3 2025 Earnings Preview [Seeking Alpha]
11/4
04:05 pm
imrx
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
Low
Report
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
11/12/2025
04:05 pm
IMRX
immuneering corporation - class a
MISS
Report
-0.3%
immuneering corporation - class a
8/13/2025
04:05 pm
IMRX
immuneering corporation - class a
IN-LINE
Report
-3.8%
immuneering corporation - class a
5/5/2025
04:05 pm
IMRX
immuneering corporation - class a
MISS
Report
-4.8%
immuneering corporation - class a
3/20/2025
04:05 pm
IMRX
immuneering corporation - class a
MISS
Report
9.1%
immuneering corporation - class a
11/12
04:19 pm
imrx
Form 10-Q Immuneering Corp For: Sep 30
Low
Report
Form 10-Q Immuneering Corp For: Sep 30
11/12
04:09 pm
imrx
Form 8-K Immuneering Corp For: Nov 12
Low
Report
Form 8-K Immuneering Corp For: Nov 12
10/21
09:03 am
imrx
Form SCHEDULE 13G Immuneering Corp Filed by: Empery Asset Management, LP
Medium
Report
Form SCHEDULE 13G Immuneering Corp Filed by: Empery Asset Management, LP
10/7
03:50 pm
imrx
Form SCHEDULE 13G Immuneering Corp Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G Immuneering Corp Filed by: FMR LLC
10/7
08:56 am
imrx
Form 4 Immuneering Corp For: Oct 03 Filed by: Feinberg Peter
Medium
Report
Form 4 Immuneering Corp For: Oct 03 Filed by: Feinberg Peter
10/3
04:16 pm
imrx
Form SCHEDULE 13G Immuneering Corp Filed by: HBM Healthcare Investments (Cayman) Ltd.
Low
Report
Form SCHEDULE 13G Immuneering Corp Filed by: HBM Healthcare Investments (Cayman) Ltd.
10/2
09:03 am
imrx
Form 4 Immuneering Corp For: Oct 01 Filed by: Morales Mallory
Low
Report
Form 4 Immuneering Corp For: Oct 01 Filed by: Morales Mallory
10/2
08:57 am
imrx
Form 4 Immuneering Corp For: Oct 01 Filed by: Neufeld Leah R
Low
Report
Form 4 Immuneering Corp For: Oct 01 Filed by: Neufeld Leah R
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register